lantheus holdings - LNTH

LNTH

Close Chg Chg %
100.44 0.37 0.36%

Open Market

100.81

+0.37 (0.36%)

Volume: 103.65K

Last Updated:

Sep 9, 2026, 11:16 AM EDT

Company Overview: lantheus holdings - LNTH

LNTH Key Data

Open

$100.45

Day Range

100.45 - 100.84

52 Week Range

49.67 - 111.86

Market Cap

$6.59B

Shares Outstanding

65.27M

Public Float

63.04M

Beta

-0.03

Rev. Per Employee

N/A

P/E Ratio

24.40

EPS

$4.22

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.38M

 

LNTH Performance

1 Week
 
-0.52%
 
1 Month
 
-0.51%
 
3 Months
 
-3.90%
 
1 Year
 
89.72%
 
5 Years
 
286.90%
 

LNTH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 10
Full Ratings ➔

About lantheus holdings - LNTH

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the following geographical segments U.S. and International. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

LNTH At a Glance

Lantheus Holdings, Inc.
201 Burlington Road
Bedford, Massachusetts 01730
Phone 1-978-671-8001 Revenue 1.54B
Industry Medical Specialties Net Income 233.56M
Sector Health Technology 2025 Sales Growth 0.502%
Fiscal Year-end 12 / 2026 Employees 1,193
View SEC Filings

LNTH Valuation

P/E Current 24.402
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 19.502
Price to Sales Ratio 2.955
Price to Book Ratio 4.386
Price to Cash Flow Ratio 11.67
Enterprise Value to EBITDA 12.605
Enterprise Value to Sales 3.126
Total Debt to Enterprise Value 0.129

LNTH Efficiency

Revenue/Employee 1,292,212.07
Income Per Employee 195,774.518
Receivables Turnover 4.122
Total Asset Turnover 0.727

LNTH Liquidity

Current Ratio 2.699
Quick Ratio 2.505
Cash Ratio 1.077

LNTH Profitability

Gross Margin 61.102
Operating Margin 20.252
Pretax Margin 20.355
Net Margin 15.15
Return on Assets 11.01
Return on Equity 21.449
Return on Total Capital 13.634
Return on Invested Capital 13.679

LNTH Capital Structure

Total Debt to Total Equity 57.188
Total Debt to Total Capital 36.382
Total Debt to Total Assets 27.98
Long-Term Debt to Equity 56.771
Long-Term Debt to Total Capital 36.117
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Lantheus Holdings - LNTH

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
935.06M 1.30B 1.53B 1.54B
Sales Growth
+119.91% +38.65% +18.32% +0.50%
Cost of Goods Sold (COGS) incl D&A
353.36M 448.84M 545.62M 599.66M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
47.93M 60.04M 64.62M 70.10M
Depreciation
14.73M 13.64M 20.82M 23.00M
Amortization of Intangibles
33.20M 46.40M 43.80M 47.10M
COGS Growth
+48.77% +27.02% +21.56% +9.90%
Gross Income
581.70M 847.59M 988.29M 941.95M
Gross Income Growth
+209.92% +45.71% +16.60% -4.69%
Gross Profit Margin
+62.21% +65.38% +64.43% +61.10%
2022 2023 2024 2025 5-year trend
SG&A Expense
510.81M 354.18M 542.43M 629.74M
Research & Development
311.68M 77.71M 168.10M 177.31M
Other SG&A
199.13M 276.47M 374.33M 452.43M
SGA Growth
+166.90% -30.66% +53.15% +16.10%
Other Operating Expense
- - - -
-
Unusual Expense
35.29M 128.78M 40.87M 5.27M
EBIT after Unusual Expense
35.61M 364.64M 405.00M 306.94M
Non Operating Income/Expense
(1.70M) 66.32M 45.65M 26.60M
Non-Operating Interest Income
2.61M 19.64M 36.84M 23.39M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
7.18M 20.02M 19.67M 19.75M
Interest Expense Growth
-7.31% +178.62% -1.75% +0.41%
Gross Interest Expense
7.18M 20.02M 19.67M 19.75M
Interest Capitalized
- - - -
-
Pretax Income
26.72M 410.94M 430.98M 313.79M
Pretax Income Growth
+135.61% +1,438.02% +4.88% -27.19%
Pretax Margin
+2.86% +31.70% +28.10% +20.35%
Income Tax
(1.35M) 84.28M 118.53M 80.23M
Income Tax - Current - Domestic
46.83M 139.91M 148.56M 57.67M
Income Tax - Current - Foreign
- - (166.00K) 967.00K
-
Income Tax - Deferred - Domestic
(48.23M) (55.99M) (30.62M) 23.47M
Income Tax - Deferred - Foreign
219.00K 359.00K 588.00K (1.87M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
28.07M 326.66M 312.44M 233.56M
Minority Interest Expense
- - - -
-
Net Income
28.07M 326.66M 312.44M 233.56M
Net Income Growth
+139.38% +1,063.86% -4.35% -25.25%
Net Margin Growth
+3.00% +25.20% +20.37% +15.15%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
28.07M 326.66M 312.44M 233.56M
Preferred Dividends
- - - -
-
Net Income Available to Common
28.07M 326.66M 312.44M 233.56M
EPS (Basic)
0.4098 4.7851 4.5151 3.4607
EPS (Basic) Growth
+138.80% +1,067.67% -5.64% -23.35%
Basic Shares Outstanding
68.49M 68.27M 69.20M 67.49M
EPS (Diluted)
0.3972 4.6507 4.3606 3.4125
EPS (Diluted) Growth
+137.61% +1,070.87% -6.24% -21.74%
Diluted Shares Outstanding
70.67M 70.24M 71.65M 68.44M
EBITDA
118.82M 553.46M 510.49M 382.31M
EBITDA Growth
+207.83% +365.78% -7.76% -25.11%
EBITDA Margin
+12.71% +42.69% +33.28% +24.80%

Snapshot

Average Recommendation HOLD Average Target Price 106.30
Number of Ratings 10 Current Quarters Estimate 1.263
FY Report Date 09 / 2026 Current Year's Estimate 5.389
Last Quarter’s Earnings 1.55 Median PE on CY Estimate N/A
Year Ago Earnings 6.08 Next Fiscal Year Estimate 6.404
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 10 10 10 9
Mean Estimate 1.26 1.34 5.39 6.40
High Estimates 1.44 1.55 5.79 7.63
Low Estimate 0.98 1.04 5.02 5.44
Coefficient of Variance 10.15 10.23 4.70 9.69

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 11
OVERWEIGHT 0 0 0
HOLD 8 9 2
UNDERWEIGHT 0 0 1
SELL 0 0 0
MEAN Hold Hold Overweight

Lantheus Holdings in the News